{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-296200","form_type":"8-K","ticker":"RXST","cik":"0001111485","company_name":"RxSight, Inc.","filed_at":"2026-07-06T20:15:17+00:00","discovered_at":"2026-07-06T20:16:00.575371+00:00","generated_at":"2026-07-06T20:16:13.057080+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"RxSight lowers FY2026 sales guidance, reports Q2 prelim revenue $32-34M, Alcon collaboration","bullets":["Preliminary Q2 2026 revenue $32-34M, including $5-7M from Alcon collaboration; sales ~$27M (24,917 LAL units, 11 LDD units).","FY2026 sales guidance lowered to $110-120M (from $120-135M); total revenue guidance $140-160M including collaboration revenue $30-40M.","Gross margin guidance raised to 73-75% (from 70-72%); operating expense guidance unchanged at $150-160M.","Strategic collaboration with Alcon to develop light-adjustable presbyopia-correcting IOLs; pipeline includes next-gen LAL, LAL+, LAL Toric.","Cash and investments ~$209M as of June 30, 2026; cites competitive trialing as headwind."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-296200","json":"https://secwatch.observer/filing/0001193125-26-296200.json","markdown":"https://secwatch.observer/filing/0001193125-26-296200.md","text":"https://secwatch.observer/filing/0001193125-26-296200.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526296200/0001193125-26-296200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526296200/rxst-20260706.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-06T20:16:13.057080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}